• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci. Transl. Med. : Elicitation of Broadly Neutralizing Influenza Antibodies in Animals with Previous Influenza Exposure

tetano

Editor, Senior Moderator
Sci Transl Med 15 August 2012:
Vol. 4, Issue 147, p. 147ra114
Sci. Transl. Med. DOI: 10.1126/scitranslmed.3004273

Research Article

Influenza
Elicitation of Broadly Neutralizing Influenza Antibodies in Animals with Previous Influenza Exposure

Chih-Jen Wei1,
Hadi M. Yassine1,
Patrick M. McTamney1,
Jason G. D. Gall2,
James R. R. Whittle1,
Jeffrey C. Boyington1 and
Gary J. Nabel1,*

+ Author Affiliations

1Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892?3005, USA.
2GenVec Inc., Gaithersburg, MD 20878, USA.

↵*To whom correspondence should be addressed. E-mail: gnabel@nih.gov

Abstract

The immune system responds to influenza infection by producing neutralizing antibodies to the viral surface protein, hemagglutinin (HA), which regularly changes its antigenic structure. Antibodies that target the highly conserved stem region of HA neutralize diverse influenza viruses and can be elicited through vaccination in animals and humans. Efforts to develop universal influenza vaccines have focused on strategies to elicit such antibodies; however, the concern has been raised that previous influenza immunity may abrogate the induction of such broadly protective antibodies. We show here that prime-boost immunization can induce broadly neutralizing antibody responses in influenza-immune mice and ferrets that were previously infected or vaccinated. HA stem?directed antibodies were elicited in mice primed with a DNA vaccine and boosted with inactivated vaccine from H1N1 A/New Caledonia/20/1999 (1999 NC) HA regardless of preexposure. Similarly, gene-based vaccination with replication-defective adenovirus 28 (rAd28) and 5 (rAd5) vectors encoding 1999 NC HA elicited stem-directed neutralizing antibodies and conferred protection against unmatched 1934 and 2007 H1N1 virus challenge in influenza-immune ferrets. Indeed, previous exposure to certain strains could enhance immunogenicity: The strongest HA stem?directed immune response was observed in ferrets previously infected with a divergent 1934 H1N1 virus. These findings suggest that broadly neutralizing antibodies against the conserved stem region of HA can be elicited through vaccination despite previous influenza exposure, which supports the feasibility of developing stem-directed universal influenza vaccines for humans.

Copyright ? 2012, American Association for the Advancement of Science


http://stm.sciencemag.org/content/4/147/147ra114
 
Back
Top Bottom